Last Updated : June 23, 2014
Details
FilesGeneric Name:
Certolizumab pegol
Project Status:
Complete
Therapeutic Area:
Ankylosing spondylitis
Manufacturer:
UCB Canada Inc.
Call for patient/clinician input open:
Brand Name:
Cimzia
Project Line:
Reimbursement Review
Project Number:
SR0385-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Ankylosing spondylitis
Recommendation Type:
List with criteria/condition
Final Recommendation:
Files
Last Updated : June 23, 2014